Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Daiichi Sankyo
Queensland Health
Merck
Mallinckrodt
Teva
Colorcon
Citi
UBS
US Department of Justice

Generated: October 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019616

« Back to Dashboard
NDA 019616 describes PENETREX, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the PENETREX profile page.

The generic ingredient in PENETREX is enoxacin. There are three drug master file entries for this compound. Additional details are available on the enoxacin profile page.

Summary for NDA: 019616

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Dec 31, 1991TE:RLD:No

Summary for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Dec 31, 1991TE:RLD:No

Expired Orange Book Patents for NDA: 019616

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
PENETREX
enoxacin
TABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis Us
PENETREX
enoxacin
TABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis Us
PENETREX
enoxacin
TABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis Us
PENETREX
enoxacin
TABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis Us
PENETREX
enoxacin
TABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis Us
PENETREX
enoxacin
TABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Federal Trade Commission
Novartis
Merck
Deloitte
UBS
Teva
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot